Changes to the website
Sponsored By
Cleveland Clinic Brain Tumor and Neuro-Oncology Center
Please Click On The Above Banner For More Details
Braintumor Website

This is a list of chages to the website.

You can Subscribe to our RSS FEED: Subscribe to our RSS feed, which delivers brain tumor news and additions to the website via RSS.
(Click HERE for details on RSS.)

Displaying items 26 to 50 of about 4484

Previous 25           Next 25
Website Changes
07/23/2017 Glioblastoma: New tools against brain cancer
07/22/2017 The Musella Foundation has awarded a pediatric brain tumor research grant
07/20/2017 Camp Jinka is a free summer program for kids and teens whose lives have been impacted by the diagnosis of a brain tumor .
07/19/2017 Human CAR-T Cell Glioblastoma Trial Generates Clues for Improving Treatment
07/19/2017 The Cedars-Sinai Department of Neurosurgery Presents Outsmarting Brain Tumors: A Conference on Brain Tumors for Patients, Families and Caregivers
07/06/2017 Comparative Study of Adjuvant Temozolomide Six Cycles Versus Extended 12 Cycles in Newly Diagnosed Glioblastoma Multiforme.
07/06/2017 Optimizing bevacizumab dosing in glioblastoma: less is more.
07/06/2017 Extent of resection and Carmustine wafer implantation safely improve survival in patients with a newly diagnosed glioblastoma: a single center experience of the current practice.
06/24/2017 No measurable gadolinium in children’s brains even after multiple doses
06/23/2017 Musella Foundation (and our copay assistance program) will be closed the week of June 25- July 3
06/21/2017 Looking Ahead: Combination Offers New Hope For Glioblastoma
06/21/2017 Cash-strapped ImmunoCellular halts brain cancer vaccine trial, eyes `strategic alternatives`
06/18/2017 Diffusion Pharmaceuticals seeks Wall Street investment while staying local
06/17/2017 A Nontoxic Pill to Replace Chemotherapy? It’s Possible
06/16/2017 Researchers assess pinworm medication for adults, children with glioblastoma
06/12/2017 First Patient Enrolled in RTOG Trial of Optune® together with Bevacizumab for Patients with Bevacizumab-Refractory Recurrent Glioblastoma
06/08/2017 FDA has approved Gleolan
06/07/2017 Medicenna’s Immunotherapy Phase 2b Trial Underway Using Brainlab Drug Delivery Technology
06/07/2017 Five years before brain cancer diagnosis, changes detectable in blood
06/07/2017 New Target Found to Attack an Incurable Brain Tumor in Children
06/07/2017 Estimating the annual frequency of synchronous brain metastasis in the United States 2010–2013: a population-based study
05/30/2017 Efficacy Results for ONC201 in Recurrent Glioblastoma Published
05/30/2017 Updated Cheryl`s story - almost 17 year survivor of a gbm!

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2017 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557

Website Design By
World Wide Websites